Literature DB >> 35754069

Antihypertensive Drugs and Risk of Bone Fractures.

Maria Velliou1, Elias Sanidas2, Aliki Zografou3, Dimitrios Papadopoulos2, Nikolaos Dalianis2, John Barbetseas2.   

Abstract

Antihypertensive drugs are among the most documented regimens worldwide with an overall survival and cardioprotective benefit. However, there is evidence that they cause symptoms of orthostatic hypotension (i.e., dizziness and syncope) placing patients at risk for falls and fall-related injuries such as bone fractures. Moreover, it seems that they might impact bone metabolism and architecture impairing bone health. The aim of this review was to summarize the accumulative literature exploring any potential association between several antihypertensive medications including diuretics, renin-angiotensin-aldosterone system inhibitors, beta-blockers and calcium channel blockers and the risk of fractures.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35754069     DOI: 10.1007/s40266-022-00955-w

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   4.271


  54 in total

1.  Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.

Authors:  Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

2.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

3.  Sympathetic Enhancement of Memory T-Cell Homing and Hypertension Sensitization.

Authors:  Liang Xiao; Luciana Simao do Carmo; Jason D Foss; Wei Chen; David G Harrison
Journal:  Circ Res       Date:  2020-01-13       Impact factor: 17.367

Review 4.  Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.

Authors:  Mahua Ghosh; Sumit R Majumdar
Journal:  Endocrine       Date:  2014-02-07       Impact factor: 3.633

Review 5.  The changing epidemiology of fall-related fractures in adults.

Authors:  C M Court-Brown; N D Clement; A D Duckworth; L C Biant; M M McQueen
Journal:  Injury       Date:  2017-03-02       Impact factor: 2.586

Review 6.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

Review 7.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

8.  The patient who falls: "It's always a trade-off".

Authors:  Mary E Tinetti; Chandrika Kumar
Journal:  JAMA       Date:  2010-01-20       Impact factor: 56.272

Review 9.  Sympathomodulatory Effects of Antihypertensive Drug Treatment.

Authors:  Guido Grassi
Journal:  Am J Hypertens       Date:  2016-02-17       Impact factor: 2.689

10.  The impact of social deprivation on mortality following hip fracture in England and Wales: a record linkage study.

Authors:  K Thorne; A Johansen; A Akbari; J G Williams; S E Roberts
Journal:  Osteoporos Int       Date:  2016-04-20       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.